Open Access. Powered by Scholars. Published by Universities.®

Medical Specialties Commons

Open Access. Powered by Scholars. Published by Universities.®

Oncology

Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 14071 - 14100 of 14285

Full-Text Articles in Medical Specialties

Oncolog, Volume 39, Number 04, October-December 1994, Linda N. Eppich, Maureen E. Goode, Kathryn L. Hale Jan 1994

Oncolog, Volume 39, Number 04, October-December 1994, Linda N. Eppich, Maureen E. Goode, Kathryn L. Hale

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Looking for solutions to ethical problems in the clinic
  • Interferon: the evolution of a biological therapy
  • Colon cancer registry coordinates treatment, education, and research


Anaemia In Pregnancy - Its Cause In The Underprivileged Class Of Karachi, Saadiya Aziz Karim, Mohammad Khurshid, A.M. Memon, Sadiqua N. Jafarey Jan 1994

Anaemia In Pregnancy - Its Cause In The Underprivileged Class Of Karachi, Saadiya Aziz Karim, Mohammad Khurshid, A.M. Memon, Sadiqua N. Jafarey

Section of Haematology/Oncology

A prospective study of the frequency and type of anaemia amongst poor urban parturients of Karachi was done. It was performed at 2 large teaching hospitals over the time span January to September, 1990. Out of 318 women studied, 104(32.7%) were anaemic (Hb levels <10gm/dl). The type of anaemia was assessed. Iron deficiency predominated and was seen amongst 63.5% of the anaemic population. There was an even distribution of other kinds of anaemia amongst the remainder of the population


Cardiovascular Risk Factors In School Children From Low Middle Income Families In Karachi, Pakistan, Salma H. Badruddin, A. Molla, Mohammad Khurshid, S. Vaz, S. Hassanali Jan 1994

Cardiovascular Risk Factors In School Children From Low Middle Income Families In Karachi, Pakistan, Salma H. Badruddin, A. Molla, Mohammad Khurshid, S. Vaz, S. Hassanali

Section of Haematology/Oncology

Serum levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and trigly cerides (TG) were determined on 239 school children aged 5-19 years belonging to lower middle class families. The mean TC, LDL-C, HDL-C and TG ranged from 3.70-4.37 mmol/L, 2.17- 2.70 mmol/L, 0.94-1.14 mmol/L, 1.07-1.26 mmol/L respectively. In general, girls had higher TC, LDL-C and HDL-C levels. There was no significant difference in the TG levels between boys and girls. Thirty-three percent of the girls and 22% of the boys had TC level _4.4 mmol/L, the level at which dietary intervention is recommended …


Basic Fibroblast Growth Factor And Fibroblast Growth Factor Receptor I Are Implicated In The Growth Of Human Astrocytomas., R S Morrison, F Yamaguchi, H Saya, J M Bruner, Alan M. Yahanda Md, Facs, L A Donehower, M Berger Jan 1994

Basic Fibroblast Growth Factor And Fibroblast Growth Factor Receptor I Are Implicated In The Growth Of Human Astrocytomas., R S Morrison, F Yamaguchi, H Saya, J M Bruner, Alan M. Yahanda Md, Facs, L A Donehower, M Berger

PCI Publications and Projects

Malignant astrocytomas are highly invasive, vascular neoplasms that comprise the majority of nervous system tumors in humans. A strong association has previously been made between malignancy in human astrocytic tumors and increased expression of certain fibroblast growth factor (FGF) family members, including basic and acidic FGF. The influence of endogenous basic FGF on glioblastoma cell growth in vitro was evaluated using basic FGF-specific antisense oligonucleotides. These studies indicated that human glioblastoma cell growth in vitro, can be inhibited by suppressing basic FGF expression. Human astrocytomas also exhibited changes in FGF receptor (FGFR) expression during the course of their progression from …


Suppressive Effects Of Transforming Factor-Β And Interleukin-10 On The Cytolytic Activity Of Murine Macrophages And Reversal By Cytokines, Chin-Hung Lin Jun 1993

Suppressive Effects Of Transforming Factor-Β And Interleukin-10 On The Cytolytic Activity Of Murine Macrophages And Reversal By Cytokines, Chin-Hung Lin

Loma Linda University Electronic Theses, Dissertations & Projects

In this study, the suppressive effects of transforming growth factor-β (TGF-β) and interleukin-10 (IL-10) on peritoneal macrophage killing of H238 target cells and the potential for reversal of the immunosuppressive effect by IL-4 and interferon-γ (IFN-γ) were investigated. The responsiveness of naive and peptone-activated macrophages was compared. The cytolytic activity for tumor cells of these effector cells was measured by percent lysis of 3H-thymidine labeled Herpes simplex virus type 2-transformed tumor cells (H238). After 18-24 hours of incubation with TGF-β or IL-10, the cytolytic activity of macro-medium alone. The immunosuppressive effect of TGF-β or IL-10 on non-activated macrophages was …


Aggressive Angiomyxoma Of Vulva, Farrukh Aijaz, Shahid Pervez, Shehnaz Wasti, Sheema H. Hassan Jun 1993

Aggressive Angiomyxoma Of Vulva, Farrukh Aijaz, Shahid Pervez, Shehnaz Wasti, Sheema H. Hassan

Department of Pathology and Laboratory Medicine

No abstract provided.


Estimation Of The Incidence Of A Rare Genetic Disease Through A Two-Tier Mutation Survey, R Chakraborty, M R Srinivasan, S Raskin Jun 1993

Estimation Of The Incidence Of A Rare Genetic Disease Through A Two-Tier Mutation Survey, R Chakraborty, M R Srinivasan, S Raskin

Faculty, Staff and Student Publications

Recent attempts to detect mutations involving single base changes or small deletions that are specific to genetic diseases provide an opportunity to develop a two-tier mutation-screening program through which incidence of rare genetic disorders and gene carriers may be precisely estimated. A two-tier survey consists of mutation screening in a sample of patients with specific genetic disorders and in a second sample of newborns from the same population in which mutation frequency is evaluated. We provide the statistical basis for evaluating the incidence of affected and gene carriers in such two-tier mutation-screening surveys, from which the precision of the estimates …


Diet And Colon Cancer Risk In The Population Of Thailand, Nithat Sirichotiratana May 1993

Diet And Colon Cancer Risk In The Population Of Thailand, Nithat Sirichotiratana

Loma Linda University Electronic Theses, Dissertations & Projects

Epidemiological studies have emphasized environmental influences, especially a diet high in animal fat and low in fiber, as major risk factors for colon cancer. In order to examine the relationship between dietary fat and fiber and occurrence of colon cancer, patient medical records from the National Cancer Institute between 1981-1991 were used for the first hospital-based case-control study of diet and colon cancer in Thailand. These records included a total of 168 cases and 357 controls. Data on the frequency consumption of various food items were obtained by using an existing food frequency questionnaire, completed as part of patient’s history …


Can An Anesthesia Machine Flush Valve Provide For Effective Jet Ventilation?, S D Gaughan, J L Benumof, G T Ozaki Apr 1993

Can An Anesthesia Machine Flush Valve Provide For Effective Jet Ventilation?, S D Gaughan, J L Benumof, G T Ozaki

Faculty, Staff and Student Publications

Transtracheal jet ventilation (TTJV) using a percutaneously inserted intravenous (IV) catheter for the patient who cannot be ventilated or tracheally intubated or, using a jet stylet for changing endotracheal tubes (ETT) in patients for whom subsequent ventilation and/or tracheal reintubation may be difficult, are extremely valuable therapeutic options. The jet ventilation system must have a sufficiently high pressure-oxygen source to drive oxygen through noncompliant tubing and through relatively small IV catheters and/or jet stylets in order to achieve adequate ventilation and oxygenation. There is no evidence that using the common gas outlet of an anesthesia machine by activating the flush …


Oncolog, Volume 38, Number 01, January-March 1993, Staff Jan 1993

Oncolog, Volume 38, Number 01, January-March 1993, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Texas Outreach Program offers neuroblastoma screening in infant
  • Cryosurgery for prostate cancer shows promise in pilot study
  • Clinicians' ability to predict cancer risk may lie in new assay


Oncolog, Volume 38, Number 04, October-December 1993, Staff Jan 1993

Oncolog, Volume 38, Number 04, October-December 1993, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Rotationplasty: an alternative that approaches limb salvage Patient Advocacy nurtures partnership between caregivers and patients
  • Chemoradiation protocol maintains control rates, has fewer toxic effects


Oncolog, Volume 38, Number 03, July-September 1993, Staff Jan 1993

Oncolog, Volume 38, Number 03, July-September 1993, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Liposomal cisplatin analogue is less toxic and more effective than cisplatin
  • Physicians can help allay fear by helping patients understand cancer risk
  • The physician's role in smoking cessation


Oncolog, Volume 38, Number 02, April-June 1993, Staff Jan 1993

Oncolog, Volume 38, Number 02, April-June 1993, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Ultraviolet radiation suppresses immune system, laboratory studies show
  • New physician network brings M. D. Anderson to local communities
  • The physician as scientist


Radiation Induced Tumor Lysis Syndrome In Patients With Leukemia, Imtiaz A. Malik, Paul Vellozo, Mohammad Khurshid, M. Ata Khan Jan 1992

Radiation Induced Tumor Lysis Syndrome In Patients With Leukemia, Imtiaz A. Malik, Paul Vellozo, Mohammad Khurshid, M. Ata Khan

Department of Medicine

Tumour lysis syndrome is a catastrophic complica­lion of treatment of certain neoplasms. It is usually seen with the tumours that have high growth fractions, increased bulk and extreme sensitivity to cytotoxic therapy. Most commonly it occurs in association with hematologic malignancies such as lymphomas and leukaemias. Rarely it has been observed with solid tumours like small cell lung cancer, seminoma and carcinoma of the breast. The syndrome develops due to massive cell lysis occurring within a few hours to a few days of starting the cytotoxic therapy. It is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcaemia. Acute renal failure, cardiac …


Oncolog, Volume 37, Issue 04, October-December 1992, Thomas W. Burke M.D., Kathryn Hale, Joseph T. Painter Md Jan 1992

Oncolog, Volume 37, Issue 04, October-December 1992, Thomas W. Burke M.D., Kathryn Hale, Joseph T. Painter Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Universal access to health care requires insurance reform, says AMA's Painter
  • Tissue conservation techniques for patients with vulvar cancer


Oncolog, Volume 37, Issue 03, July-September 1992, Scott M. Lippman Md, Mark A. Schusterman M.D., Eva Singletary Md, Merrick I. Ross M.D., Daryl Ogden Ms Jan 1992

Oncolog, Volume 37, Issue 03, July-September 1992, Scott M. Lippman Md, Mark A. Schusterman M.D., Eva Singletary Md, Merrick I. Ross M.D., Daryl Ogden Ms

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Retinoic acid/interferon combination shows promising response rates
  • Cross-matching test helps find donors for patients in dire need of platelets
  • Silicone gel-filled implants: Women should have the option to choose


Oncolog, Volume 37, Issue 02, April-June 1992, Ralph S. Freedman Md, Phd, Bartlett D. Moore Iii,Phd, Nicholas H.A. Terry Phd Jan 1992

Oncolog, Volume 37, Issue 02, April-June 1992, Ralph S. Freedman Md, Phd, Bartlett D. Moore Iii,Phd, Nicholas H.A. Terry Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • The primacy of patient welfare
  • Potential doubling time of tumors may be the key to accurate prognosis, appropriate treatment
  • Cognitive deficits in survivors of childhood cancers


Oncolog, Volume 37, Issue 01, January-March 1992, Roman Perez-Soler Md, Waldemar Priebe Md, Michael Needle, Sidney Wallace Md Jan 1992

Oncolog, Volume 37, Issue 01, January-March 1992, Roman Perez-Soler Md, Waldemar Priebe Md, Michael Needle, Sidney Wallace Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Clinician and chemist forge new approach to liposome research
  • Computerized network enhances interdisdplinary patient management
  • Neurofibromatosis: a new clinic brings new opportunities


Oncolog, Volume 36, Issue 04, October-December 1991, Stephen S. Kroll M.D., James M. Bowen Phd Oct 1991

Oncolog, Volume 36, Issue 04, October-December 1991, Stephen S. Kroll M.D., James M. Bowen Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Antisense RNA technology successfully blocks K-ras-induced cancer
  • Immediate breast reconstruction reduces the trauma of mastectomy
  • The human face of data


Statistical Interpretation Of Dna Typing Data, R Chakraborty Oct 1991

Statistical Interpretation Of Dna Typing Data, R Chakraborty

Faculty, Staff and Student Publications

No abstract provided.


Oncolog, Volume 36, Issue 03, July-September 1991, Emil J. Freireich Md, James M. Bowen Phd Jul 1991

Oncolog, Volume 36, Issue 03, July-September 1991, Emil J. Freireich Md, James M. Bowen Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • From cell culture to clinical protocol: In cancer research, the goals of scientist and clinician converge New clinic treats depressed cancer patients
  • Half-century of progress in leukemia research


Inclusion Of Data On Relatives For Estimation Of Allele Frequencies, R Chakraborty Jul 1991

Inclusion Of Data On Relatives For Estimation Of Allele Frequencies, R Chakraborty

Faculty, Staff and Student Publications

No abstract provided.


Efficient Immortalization Of Luminal Epithelial Cells From Human Mammary Gland By Introduction Of Simian Virus 40 Large Tumor Antigen With A Recombinant Retrovirus, Bartek J, Bartkova J, Kyprianou N, El-Nasir Lalani, Staskova Z, Shearer M, Chang S, Taylor Papadimitriou J May 1991

Efficient Immortalization Of Luminal Epithelial Cells From Human Mammary Gland By Introduction Of Simian Virus 40 Large Tumor Antigen With A Recombinant Retrovirus, Bartek J, Bartkova J, Kyprianou N, El-Nasir Lalani, Staskova Z, Shearer M, Chang S, Taylor Papadimitriou J

Department of Pathology and Laboratory Medicine

When defined in terms of markers for normal cell lineages, most invasive breast cancer cells correspond to the phenotype of the common luminal epithelial cell found in the terminal ductal lobular units. Luminal epithelial cells cultured from milk, which have limited proliferative potential, have now been immortalized by introducing the gene encoding simian virus 40 large tumor (T) antigen. Infection with a recombinant retrovirus proved to be 50-100 times more efficient than calcium phosphate transfection, and of the 17 cell lines isolated, only 5 passed through a crisis period as characterized by cessation of growth. When characterized by immunohistochemical staining …


Oncolog, Volume 36, Issue 02, April-June 1991, Gilbert H. Fletcher M.D., James M. Bowen Phd Jan 1991

Oncolog, Volume 36, Issue 02, April-June 1991, Gilbert H. Fletcher M.D., James M. Bowen Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Redefining the risks of chemotherapy during pregnancy Renewing the assault on pancreatic cancer
  • Significance of cancer volume in radiotherapy


Oncolog, Volume 36, Issue 01, January-March 1991, Michael S. Ewer Md, Mph, T. C. Hsu Ph.D., John R. Redman M.D. Jan 1991

Oncolog, Volume 36, Issue 01, January-March 1991, Michael S. Ewer Md, Mph, T. C. Hsu Ph.D., John R. Redman M.D.

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Decision making in critical illness: Who knows best?
  • Successful Hodgkin's disease treatment can also preserve reproductive function
  • Chromosomes and cancer


Pharmacokinetics, Immune Response, And Biodistribution Of Iodine-131-Labeled Chimeric Mouse/Human Igg1, K 17-1a Monoclonal Antibody, Ruby Meredith, Albert Lobuglio, Walter Plott, Roger Orr, Ivan Brezovich, Charles Russell, Elizabeth Harvey, Michael Yester, Mansoor Saleh Jan 1991

Pharmacokinetics, Immune Response, And Biodistribution Of Iodine-131-Labeled Chimeric Mouse/Human Igg1, K 17-1a Monoclonal Antibody, Ruby Meredith, Albert Lobuglio, Walter Plott, Roger Orr, Ivan Brezovich, Charles Russell, Elizabeth Harvey, Michael Yester, Mansoor Saleh

Haematology and Oncology, East Africa

Pharmacokinetics,immunogenicity,and biodistributionof a 131I-Iabeledmouse/human chimenc monoclonal antibody (C17-1A) was studiedin six metastaticcoloncancerpatients. Pharmacokinetics obtalned from serum radioactivity or chi mera concentration were identical after 5 mCi of 131I(>17-1A withmeanalphahalf-livesof 17.6±2.3 and19.7±2.9 and meanbeta half-livesof 100.9±16.1 and 106.4±14.1 hr, respectively. HPLC analysis documented the monomeric chi rneiic17-lA withoutevidenceof immunecomplexesorfree 1311 None of the patients developed antibody after ‘31I-chi merle17-1A exposure.Radiolocalizationoccurredin known areas of disease >4 cm in all patients. The half-life of total body radioactivity was 58 ±7 hr by whole-body counts and 64 ±13 hr by urine measurements. Whole-body and bone marrow dose estimates ranged from 0.75-1 .03 and …


The Role Of Small Peptides In Cancer Physiology And Chemotherapy, Bao-Ling Tsay Jan 1990

The Role Of Small Peptides In Cancer Physiology And Chemotherapy, Bao-Ling Tsay

Theses and Dissertations in Biomedical Sciences

The targeting of proven anticancer drugs specifically to cancer cells would provide a unique opportunity to restrict neoplasms without damaging the cancer patient. The present research utilizes the phenomenon of illicit transport, i.e. the coupling of normally impermeant metabolites to permeant metabolites, in targeting the drug melphalan to mouse Ehrlich ascites tumor cells. The dipeptide beta-alanyl-melphalan was synthesized and tested in vitro for toxicity towards mouse Ehrlich ascites tumor cells, mouse liver cells, and mouse 3T3 embryonic cells. The parent compound, melphalan, was used as a control treatment. In addition, both melphalan and beta-alanyl-melphalan were utilized in in vivo chemotherapeutic …


Oncolog, Volume 35, Number 03, July-September 1990, Staff Jan 1990

Oncolog, Volume 35, Number 03, July-September 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Treatment Team Addresses Needs of the Dying Patient
  • Fludarabine Opens a New Dimension in Chronic Lymphocytic Leukemia Research


Oncolog, Volume 35, Number 02, April-June 1990, Staff Jan 1990

Oncolog, Volume 35, Number 02, April-June 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Chemotherapy for Brain Metastasis Sees Progress in the Last Decade
  • Researchers Hope Chemoprevention Will Reverse Tumorigenic Process
  • Immunocytochemical Assays for Steroid Receptors: A New Application for Fine Needle Aspiration


Oncolog, Volume 35, Number 04, October-December 1990, Staff Jan 1990

Oncolog, Volume 35, Number 04, October-December 1990, Staff

OncoLog MD Anderson's Report to Physicians (All issues) Archives

  • Search Continues for the Cause of Cervical Cancer
  • Clinical Applications of Fine Needle Aspiration Increase
  • The Uncertain Role of Adjuvant Systemic Therapy
  • Breast Conservation Should Be the Patient's Choice